REGENXBIO Inc. (RGNX)
REGENXBIO Inc. (RGNX)
$33.93 USD
Updated Aug 23 12:00am
Add RGNX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
RGNX Stock Chart More Charts
RGNX Price/Volume Stats
| Current price | $33.93 |
| Prev. close | $35.07 |
| Day low | $33.73 |
| Day high | $36.02 |
| 50-day MA | $45.29 |
| 200-day MA | $49.60 |
| 52-week high | $83.45 |
| 52-week low | $33.73 |
| Volume | 422,800 |
| Avg. volume | 554,753 |
| Dividend yield | N/A |
| Market Cap | 1.25B |
REGENXBIO Inc. (RGNX) Company Bio
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company was founded in 2009 and is based in Rockville, Maryland.
Top Stories View All
Stock of the Week: Verizon Communications (VZ)
Best & Worst Performing Stock Industries for August 23, 2019
Best & Worst Performing Mid Cap Stocks for August 23, 2019
Best & Worst Performing Small Cap Stocks for August 23, 2019
Best & Worst Performing Mega Cap Stocks for August 23, 2019
View All Top Stories
Loading social stream, please wait...